China
Medical Technologies, Inc. (CMED) (Nasdaq: CMED), a leading China-based
advanced in-vitro diagnostic ("IVD") company, and Leica Biosystems, a division
of Leica Microsystems, a world leader in microscopes and scientific
instruments, today announced that they have established a sales, research and
development collaboration to co-develop and market automated FISH kits to be
used on the Leica BOND system. CMED will sell the Automated FISH Kits in China
and Leica will have an option to sell the FISH kits in the rest of the world.
Under the
collaboration, CMED and Leica Microsystems will jointly develop automated FISH
solutions for tissue sample tests on HER-2, EGFR and TOP2A on the Leica BOND system,
an automated advanced staining platform. HER-2, EGFR and TOP2A are genes in
connection with the targeted cancer therapy drugs for breast cancer, lung cancer
and stomach cancer patients. Automation of these FISH tests on the Leica BOND system
will enable pathology laboratories and independent service laboratories to run
these diagnostic tests more efficiently and with higher and more consistent
quality. The automation of FISH tests will also help users to reduce the work
load pressure created by increasing test volumes. Both parties agreed to add further
FISH applications into the collaboration during the term, including for
cytology and pre-natal applications.
"These
collaborations with Leica mark a significant milestone for us," commented Mr.
Xiaodong Wu, Chairman and Chief Executive Officer of CMED. "We believe that
FISH applications will be more widely used in various clinical applications on
automated basis in the future. By partnering with Leica, one of the leading
global players anatomic pathology, we can provide more efficient and higher
quality FISH diagnostic solutions to the end users not only in China, but also
in the global markets through Leica's extensive global network."
"CMED is
the market leader for FISH based diagnostics in China and has played a key role
in the rapid development in the use of FISH in China, especially for tissue
based companion diagnostic testing. This partnership will help Leica and CMED
to offer customers in China a broad test menu of high quality FISH tests
automated on the Leica BOND system," commented Arnd Kaldowski, President of Leica
Biosystems.
For further information visit
www.leica-microsystems.com
Subscribe to any of our newsletters for the latest on new laboratory products, industry news, case studies and much more!
Request your free copies HERE
Popular this Month
Top 10 most popular articles this month
Today's Picks
Looking for a Supplier?
Search by company or by product
Please note Lab Bulletin does not sell, supply any of the products featured on this website. If you have an enquiry, please use the contact form below the article or company profile and we will send your request to the supplier so that they can contact you directly.
Lab Bulletin is published by newleaf marketing communications ltd.